Cancer Gene Screens Save Money, Not Lives (CME/CE)

(MedPage Today) — Screening patients with metastatic colorectal cancer for mutations in the KRAS and BRAF genes before starting targeted drug therapy saves costs, but does not improve survival chances, researchers said.

Post a Comment

Comments are closed.